Alliance Pharma (LSE:APH) Total Assets : £513.7 Mil (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Total Assets?

Alliance Pharma's Total Assets for the quarter that ended in Jun. 2023 was £513.7 Mil.

Warning Sign:

If a company builds assets at 8.8% a year, faster than its revenue growth rate of 7.6% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Alliance Pharma's average Total Assets Growth Rate was -6.10% per year. During the past 3 years, the average Total Assets Growth Rate was 9.10% per year. During the past 5 years, the average Total Assets Growth Rate was 8.80% per year. During the past 10 years, the average Total Assets Growth Rate was 19.60% per year.

During the past 13 years, Alliance Pharma's highest 3-Year average Total Assets Growth Rate was 76.30%. The lowest was 5.20%. And the median was 18.50%.

Total Assets is connected with ROA %. Alliance Pharma's annualized ROA % for the quarter that ended in Jun. 2023 was 1.94%. Total Assets is also linked to Revenue through Asset Turnover. Alliance Pharma's Asset Turnover for the quarter that ended in Jun. 2023 was 0.15.

Alliance Pharma Total Assets Historical Data

The historical data trend for Alliance Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Total Assets Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Assets

Get a 7-Day Free Trial

403.61

407.64

508.85

503.49

537.41

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Assets	Get a 7-Day Free Trial															513.96	503.49	548.57	537.41	513.72

Alliance Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Alliance Pharma's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	287.661	+	249.75
	=	537.4

Alliance Pharma's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	276.959	+	236.761
	=	513.7

Alliance Pharma (LSE:APH) Total Assets Explanation

Total Assets is connected with ROA %.

Alliance Pharma's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	10.218	/	( (537.411	+	513.72)	/ 2 )
	=	10.218	/	525.5655
	=	1.94 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Alliance Pharma's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	81.398	/	( (537.411	+	513.72)	/ 2 )
=	81.398	/	525.5655
=	0.15

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Alliance Pharma Total Assets Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).